|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,609.70 INR | +2.58% |
|
+10.46% | -9.43% |
| 30/06 | India's Torrent Pharma to acquire controlling stake in JB Chem and Pharma | RE |
| 27/06 | Lilly to launch Mounjaro pen in India as Novo rivalry heats up in mega market | RE |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||
Pharmaceuticals | 5.87TCr | 6.22TCr | 7.78TCr | 8.75TCr | 10TCr | |
Total Assets | 5.07TCr | 6.37TCr | 9.15TCr | 9.72TCr | 12TCr | |
Interest Expense | -22Cr | -19Cr | -56Cr | -40Cr | -29Cr | |
Income Tax Expense | 381.59Cr | 398.58Cr | 521.64Cr | 361.56Cr | 457.59Cr | |
CAPEX | -227.97Cr | -308.43Cr | -464.86Cr | -789.02Cr | -315.33Cr | |
EBT | 1.44TCr | 1.69TCr | 1.96TCr | 1.66TCr | 2.38TCr | |
D&A | 96Cr | 115.44Cr | 161.64Cr | 320.81Cr | 389.52Cr | |
Net Income | 1.03TCr | 1.27TCr | 1.43TCr | 1.28TCr | 1.91TCr |
Geographical Revenue Distribution History
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
India | 5.79TCr | 6.03TCr | 7.59TCr | 8.45TCr | 9.52TCr | |
Total Assets | 5.01TCr | 6.06TCr | 4.35TCr | 4.84TCr | 4.86TCr | |
Outside India | 76Cr | 185.9Cr | 186.81Cr | 295.83Cr | 813.46Cr | |
Total Assets | 67Cr | 313.59Cr | 11Cr | 30Cr | 33Cr | |
Unallocated | - | 9.47Cr | - | - | - |
- Stock Market
- Equities
- MANKIND Stock
- Financials Mankind Pharma Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition